Moberg Pharma AB (publ)
MOB
Rank in Stocks
#22782
Moberg Pharma AB (publ) functions as a pharmaceutical company, dedicated to... Moberg Pharma AB (publ) functions as a pharmaceutical company, dedicated to both crafting and globally marketing medical solutions throughout Europe, the United States, and various international territories. A notable product within its development portfolio is MOB-015, a treatment designed for nail fungus, which has successfully concluded its Phase III clinical trials. Established in 2006, this enterprise is headquartered in Bromma, Sweden. It was previously known as Moberg Derma AB (publ) until its rebranding to the current name in May 2013.
Share Price
$1.05
Last synced: 2026-11-09
Market Cap
$49.77M
Change (1 day)
0.34%
Change (1 year)
-2.94%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Moberg Pharma AB (publ) (MOB)
Category
Healthcare
Dividend history for Moberg Pharma AB (publ) (MOB)
Moberg Pharma AB (publ) (stock symbol: MOB) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $4.83
Dividend yield (TTM) : 0.00%
The sum of all dividends (adjusted for stock splits) is : $4.83
Dividend yield (TTM) : 0.00%
Dividend payments for Moberg Pharma AB (publ) (MOB) from 2019 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $4.83 | 0.00% |
| 2019 | $4.83 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.85 | 0.00% |
| 2019 | $0.85 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 2.00% |
CH
|
|
| 62.00% |
IL
|
